205 related articles for article (PubMed ID: 9308561)
1. Rediscovering mycophenolic acid: a review of its mechanism, side effects, and potential uses.
Kitchin JE; Pomeranz MK; Pak G; Washenik K; Shupack JL
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):445-9. PubMed ID: 9308561
[TBL] [Abstract][Full Text] [Related]
2. [Mycophenolate mofetil: a new immunosuppressive drug in dermatology and its possible uses].
Geilen CC; Orfanos-Boeckel H; Offermann G; Orfanos CE
Hautarzt; 2000 Feb; 51(2):63-9. PubMed ID: 10743574
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil.
Zwerner J; Fiorentino D
Dermatol Ther; 2007; 20(4):229-38. PubMed ID: 17970888
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolic acid in dermatology a century after its discovery.
Strathie Page SJ; Tait CP
Australas J Dermatol; 2015 Feb; 56(1):77-83. PubMed ID: 25557632
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil in pediatric renal transplantation.
Weber LT; Höcker B; Mehls O; Tönshoff B
Minerva Urol Nefrol; 2003 Mar; 55(1):91-9. PubMed ID: 12773970
[TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil: a dermatologic perspective.
Mydlarski PR
Skin Therapy Lett; 2005 Apr; 10(3):1-6. PubMed ID: 15986076
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic plaque-stage psoriasis and psoriatic arthritis with mycophenolate mofetil.
Grundmann-Kollmann M; Mooser G; Schraeder P; Zollner T; Kaskel P; Ochsendorf F; Boehncke WH; Kerscher M; Kaufmann R; Peter RU
J Am Acad Dermatol; 2000 May; 42(5 Pt 1):835-7. PubMed ID: 10775866
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil and skin diseases.
Hartmann M; Enk A
Lupus; 2005; 14 Suppl 1():s58-63. PubMed ID: 15803935
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil as a systemic antipsoriatic agent: positive experience in 11 patients.
Geilen CC; Arnold M; Orfanos CE
Br J Dermatol; 2001 Mar; 144(3):583-6. PubMed ID: 11260019
[TBL] [Abstract][Full Text] [Related]
10. Psoriasis vulgaris treated successfully with mycophenolate mofetil.
Haufs MG; Beissert S; Grabbe S; Schütte B; Luger TA
Br J Dermatol; 1998 Jan; 138(1):179-81. PubMed ID: 9536244
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil in dermatology.
Orvis AK; Wesson SK; Breza TS; Church AA; Mitchell CL; Watkins SW
J Am Acad Dermatol; 2009 Feb; 60(2):183-99; quiz 200-2. PubMed ID: 19150270
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update.
Staatz CE; Tett SE
Arch Toxicol; 2014 Jul; 88(7):1351-89. PubMed ID: 24792322
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil in autoimmune and inflammatory skin disorders.
Nousari HC; Sragovich A; Kimyai-Asadi A; Orlinsky D; Anhalt GJ
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):265-8. PubMed ID: 10025760
[TBL] [Abstract][Full Text] [Related]
14. Plasma trough levels of mycophenolic acid do not correlate with efficacy and safety of mycophenolate mofetil in psoriasis.
Daudén E; Sánchez-Peinado C; Ruiz-Genao D; García-F-Villalta M; Onate MJ; García-Díez A
Br J Dermatol; 2004 Jan; 150(1):132-5. PubMed ID: 14746627
[TBL] [Abstract][Full Text] [Related]
15. [Use of mycophenolate mofetil in kidney transplantation].
Hrvacevic R; Ignjatovic Lj; Vavic N
Vojnosanit Pregl; 2001; 58(4):415-9. PubMed ID: 11712223
[TBL] [Abstract][Full Text] [Related]
16. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).
Allison AC; Eugui EM
Clin Transplant; 1996 Feb; 10(1 Pt 2):77-84. PubMed ID: 8680053
[TBL] [Abstract][Full Text] [Related]
17. Superior efficacy of enteric-coated mycophenolate vs mycophenolate mofetil in de novo transplant recipients: pooled analysis.
Salvadori M; Bertoni E; Budde K; Holzer H; Civati G; Lien B; Arns W
Transplant Proc; 2010 May; 42(4):1325-8. PubMed ID: 20534293
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil: An update.
Villarroel MC; Hidalgo M; Jimeno A
Drugs Today (Barc); 2009 Jul; 45(7):521-32. PubMed ID: 19834629
[TBL] [Abstract][Full Text] [Related]
19. Long-term safety of mycophenolate mofetil and cyclosporine: a review.
Buell C; Koo J
J Drugs Dermatol; 2008 Aug; 7(8):741-8. PubMed ID: 18720690
[TBL] [Abstract][Full Text] [Related]
20. Enteric-coated mycophenolate sodium: safe conversion from mycophenolate mofetil in maintenance renal transplant recipients.
Budde K; Glander P; Diekmann F; Dragun D; Waiser J; Fritsche L; Neumayer HH
Transplant Proc; 2004 Mar; 36(2 Suppl):524S-527S. PubMed ID: 15041401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]